Clinical trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
NCT03089281 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT03089281 |
|---|---|
| Title | Strategic Management to Optimize Response To Cardiac Resynchronization Therapy |
| Official title | Strategic Management to Optimize Response To Cardiac Resynchronization Therapy |
| Acronym | SMART CRT |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | CRT-D |
| Enrollment | 699 |
| Start date | Aug 1, 2017 |
| Primary completion | Sep 15, 2020 |
| Completion | Sep 15, 2020 |
| First posted | Mar 24, 2017 |
| Last update posted | Apr 5, 2022 |
| Countries | Canada, France, Germany, Ireland, Italy, Japan, Netherlands, Spain, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: